Enhanced transdermal lymphatic drug delivery of hyaluronic acid modified transfersomes for tumor metastasis therapy

Chem Commun (Camb). 2015 Jan 28;51(8):1453-6. doi: 10.1039/c4cc08746a.

Abstract

A novel hyaluronic acid modified transfersome was prepared to deliver drugs to lymphatics through the transdermal route. Doxorubicin loaded HA-GMS-T was able to efficiently penetrate into the deep skin tissue, leading to enhanced absorption by lymphatics. Most importantly, hyaluronic acid effectively improved the uptake of drug loaded nanocarriers by tumor cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Cutaneous
  • Animals
  • Antibiotics, Antineoplastic / administration & dosage*
  • Antibiotics, Antineoplastic / chemistry
  • Antibiotics, Antineoplastic / pharmacokinetics
  • Cell Line
  • Doxorubicin / administration & dosage*
  • Doxorubicin / chemistry
  • Doxorubicin / pharmacokinetics
  • Glycerol / administration & dosage
  • Glycerol / analogs & derivatives
  • Glycerol / chemistry
  • Hyaluronic Acid / administration & dosage*
  • Hyaluronic Acid / chemistry
  • Liposomes
  • Liver / metabolism
  • Lymphatic System / metabolism
  • MCF-7 Cells
  • Mice
  • Nanoparticles / administration & dosage*
  • Nanoparticles / chemistry
  • Neoplasms / drug therapy
  • Neoplasms / metabolism*
  • Rats, Wistar
  • Skin / metabolism
  • Skin Absorption*
  • Stearates / administration & dosage
  • Stearates / chemistry

Substances

  • Antibiotics, Antineoplastic
  • Liposomes
  • Stearates
  • glycerol 1-stearate
  • Doxorubicin
  • Hyaluronic Acid
  • Glycerol